Olema Pharmaceuticals Cash Flow Statement (2020-2026) | OLMA

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-16.41M-17.66M-21.65M-23.04M-32.88M-22.60M-26.25M-28.30M-20.05M-21.42M-26.86M-30.99M-30.42M-34.69M-33.47M-30.35M-43.82M-42.23M-46.07M-53.21M
Share-based Compensation (Quarter)
3.92M4.16M4.63M4.96M4.73M4.28M4.86M4.63M4.17M4.11M4.35M4.91M5.72M5.63M6.32M4.38M4.69M4.25M4.27M10.15M
Gains from Sales and Divestitures (Quarter)
0.12M0.19M0.24M0.05M0.10M0.05M0.20M0.05M0.10M0.05M0.19M0.04M0.05M0.09M0.09M
Gains from Investment Securities (Quarter)
5.58M0.09M5.77M2.66M2.93M8.33M8.38M9.84M9.28M8.98M8.67M0.11M0.18M3.30M11.35M0.11M4.25M4.74M4.41M
Non-cash Items (Quarter)
80.76M71.76M11.37M1.03M1.09M0.35M0.26M2.03M31.57M53.94M61.75M40.73M37.10M44.23M7.52M1.32M1.93M51.96M235.66M91.89M
Cash from Operations (Quarter)
-8.90M-12.10M-18.60M-17.90M-26.46M-17.99M-19.71M-20.39M-22.12M-22.74M-18.48M-23.50M-27.55M-27.02M-26.28M-43.98M-29.88M-34.53M-38.33M-45.99M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.07M-0.08M1.44M0.32M0.33M0.33M0.33M0.33M0.33M0.32M0.32M0.29M0.29M0.29M0.29M0.29M0.29M0.30M0.30M0.30M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)
0.03M0.05M0.07M0.08M0.09M0.09M0.10M0.10M0.10M0.09M0.09M0.09M0.09M0.10M0.12M0.13M0.13M0.04M0.19M0.12M
Change in Working Capital
Change in Account Payables (Quarter)
0.01M-0.20M-0.16M0.24M-0.15M-0.11M0.36M0.31M0.94M0.58M0.49M4.96M-3.30M-1.67M2.52M-4.31M0.74M2.39M5.77M-5.68M
Change in Accured Expenses (Quarter)
2.88M1.18M-0.50M-0.11M2.03M1.37M3.74M2.69M-5.38M0.47M5.17M-0.40M3.56M5.82M2.23M-11.25M12.70M5.90M3.63M1.30M
Investing Activities
Capital Expenditures (Quarter)
0.74M0.10M0.70M0.03M0.02M0.14M0.17M0.15M0.01M
Change in Acquisitions & Divestments (Quarter)
66.00M119.45M26.66M148.75M57.00M38.75M61.00M61.76M64.50M70.50M54.00M56.10M77.29M93.39M74.81M97.77M67.10M88.92M91.17M74.47M
Cash from Investing Activities (Quarter)
10.93M-12.78M6.00M25.57M29.41M20.16M16.34M37.39M14.11M-25.44M-30.91M-20.14M-4.88M45.92M-114.42M-45.08M34.23M17.27M-162.18M4.53M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
0.06M0.48M0.03M0.01M0.11M0.22M1.33M0.87M127.31M0.92M14.90M0.09M0.59M0.24M0.23M0.04M7.88M8.43M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)
0.06M0.82M0.03M0.06M0.11M0.27M0.22M2.04M130.63M0.52M8.82M15.61M0.09M244.30M0.22M-2.52M0.04M213.55M45.70M
Change in Cash (Quarter)
2.54M-24.82M-11.79M7.70M3.02M2.28M-3.10M17.22M-5.96M82.45M-48.87M-34.82M-16.83M19.00M103.59M-88.84M1.83M-17.21M13.04M4.25M
Free Cash Flow (Quarter)
-9.65M-12.19M-19.30M-17.93M-26.48M-18.13M-19.88M-20.39M-22.12M-22.74M-18.48M-23.65M-27.56M-27.02M-26.28M-43.98M-29.88M-34.53M-38.33M-45.99M
Net Cash Flow (Quarter)
2.02M-24.82M-11.79M7.70M3.02M2.28M-3.10M17.22M-5.96M82.45M-48.87M-34.82M-16.83M19.00M103.59M-88.84M1.83M-17.21M13.04M4.25M